Big Pharma Split Corp.
PRM.TO · TSX
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -CA$487 | -CA$1,778 | CA$1,240 | -CA$78 |
| Dep. & Amort. | CA$0 | CA$0 | CA$0 | CA$0 |
| Deferred Tax | CA$0 | CA$0 | CA$0 | CA$0 |
| Stock-Based Comp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Change in WC | -CA$29 | -CA$29 | CA$17 | CA$10 |
| Other Non-Cash | CA$372 | CA$934 | -CA$1,679 | -CA$722 |
| Operating Cash Flow | CA$870 | -CA$873 | -CA$422 | -CA$790 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Acquisitions | CA$0 | CA$0 | CA$0 | CA$0 |
| Inv. Purchases | CA$0 | CA$0 | CA$0 | CA$0 |
| Inv. Sales/Matur. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Inv. Act. | CA$0 | CA$0 | -CA$0 | CA$0 |
| Investing Cash Flow | CA$0 | CA$0 | CA$0 | CA$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CA$684 | CA$546 | CA$738 | -CA$132 |
| Stock Issued | CA$673 | CA$343 | CA$0 | CA$445 |
| Stock Repurch. | CA$0 | -CA$445 | -CA$24 | -CA$807 |
| Dividends Paid | -CA$1,021 | -CA$700 | -CA$804 | -CA$736 |
| Other Fin. Act. | CA$294 | CA$0 | CA$0 | CA$0 |
| Financing Cash Flow | CA$630 | -CA$256 | -CA$91 | -CA$1,229 |
| Forex Effect | CA$738 | CA$567 | CA$1,902 | CA$1,826 |
| Net Chg. in Cash | CA$1,224 | -CA$562 | CA$1,389 | -CA$193 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CA$1,031 | CA$1,593 | CA$204 | CA$398 |
| End Cash | CA$2,254 | CA$1,031 | CA$1,593 | CA$204 |
| Free Cash Flow | CA$870 | -CA$873 | -CA$422 | -CA$790 |